article thumbnail

Competition is on the horizon for costly narcolepsy treatments

pharmaphorum

But increased competition is on the horizon. Both the physician and the patient have to be registered and the drugs can only come from a primary source through limited distribution. Competition starts to heat up. The post Competition is on the horizon for costly narcolepsy treatments appeared first on. About the author.

article thumbnail

 The US accounts for more than 40% of all health spending.

World of DTC Marketing

Hospitals, physicians, and clinical care made up more than half of the total healthcare spending in 2019. The lack of choice limits competition, which can drive prices higher. A KFF survey from March 2019 found that about one-fourth of U.S. residents pay more for each interaction. of every healhealthcarelar spent.

Insurance 154
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Lupkynis approved for the treatment of LN in the EU and UK

Pharmaceutical Technology

However, the lack of in-person administration by physicians will likely also impact patient compliance. Overall, Aurinia’s Lupkynis is expected to face tough competition from Benlysta in LN, which received FDA approval in December 2020 and EMA approval in May 2021.

article thumbnail

How to Adapt Your Marketing Now That Private Practice Has Become an “Endangered Species”

Healthcare Success

We’re living through a seismic shift in how physicians deliver medical care in the United States. . percent of physicians worked in physician-owned practices. At the end of 2020—for the first time ever—less than half ( 49.1% ) of patient care physicians worked in private practice. . In other words, only 26.1%

article thumbnail

9 Healthcare Marketing Trends to Embrace in 2023

Healthcare Success

In this blog, I share nine healthcare marketing trends you need to embrace in 2023 to remain competitive in today’s ever-changing healthcare marketplace. Competition from Retail and Telehealth Disruptors Continues to Intensif y. The COVID-19 pandemic supercharged a new type of competition for legacy healthcare organizations.

article thumbnail

HCP Perspective on Amazon Care

InCrowd

In September InCrowd surveyed attending physicians, nurses, medical residents and fellows on their thoughts about Amazon Care. Amazon Care was first launched in 2019 with the hopes of providing 24/7 telehealth services and in-person care to customers in the US.

Retail 52
article thumbnail

T2D market growth driven by novel GLP-1RAs and once-weekly basal insulin therapies

Pharmaceutical Technology

Type 2 diabetes (T2D) is a crowded and competitive landscape with multiple “me-too,” generic and biosimilar drugs entering the market, with market growth primarily driven by an increasing prevalent population across nine major markets (9MM: US, France, Germany, Italy, Spain, UK, Japan, China, and India).